Hillary Clinton Throws a Straight Jab to Pershing Square’s Valeant Pharmaceuticals (ticker VRX; 1/28/2016)

Financial Highlights (Gurufocus.com):
Operating margin (%) 19.61
Net-margin (%) 5.69
ROE (%) 9.78
ROA (%) 1.52

P/E(ttm) 58.88

in USD*
Revenue (TTM): 9.9 Billion
Profit (TTM): 605 Million
Total Cash: 1.4 Billion
Long-term Debt: 30.1 Billion
Owner’s Earnings: 2 Billion

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s